Jamila Louahed

Person

Rixensart, BE

People

Patents Grantslast 30 patents

Information Patent Grant
Fusion protein
- Patent number 8,309,096
- Issue date Nov 13, 2012
- GlaxoSmithKline Biologicals SA
- Normand Blais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF I...
- Publication number 20150147350
- Publication date May 28, 2015
- GlaxoSmithKline LLC
- Catherine Marie Ghislaine Gerard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method
- Publication number 20110070268
- Publication date Mar 24, 2011
- GlaxoSmithKline Biologicals S.A.
- Vincent Brichard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for Classifying Cancer Patients as Responder or Non-Responde...
- Publication number 20100247580
- Publication date Sep 30, 2010
- Thierry Coche
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fusion Protein
- Publication number 20100029912
- Publication date Feb 4, 2010
- GlaxoSmithKline Biologicals S.A.
- Normand Blais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method For Identifying Whether A Patient Will Be Responder or Not t...
- Publication number 20100021424
- Publication date Jan 28, 2010
- Vincent Brichard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined w...
- Publication number 20100008980
- Publication date Jan 14, 2010
- Vincent Brichard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jamila Louahed

Person

Patents Grantslast 30 patents

Fusion protein

Patents Applicationslast 30 patents

Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF I...

Method

Method for Classifying Cancer Patients as Responder or Non-Responde...

Fusion Protein

Method For Identifying Whether A Patient Will Be Responder or Not t...

Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined w...